Zobrazeno 1 - 10
of 28
pro vyhledávání: '"L P, Kasi"'
Autor:
Panayiotis J. Asimacopoulos, L. P. Kasi, David J. Yang, Dimitrios Andreopoulos, William C. Cole, Satish G. Jhingran, E. Edmund Kim
Publikováno v:
Nuclear Medicine and Biology. 29:185-190
We describe a method by which endocytosis-based radiolabeling of WBC is achieved using 99m Tc-liposomes of optimal size and charge, and of a composition that assures both in vitro (whole blood) and intracellular stability of the radiopharmaceutical.
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 126:161-167
Purpose: The majority of patients with germ cell tumors are cured by multimodality therapy that consists of cisplatin-based chemotherapy and/or surgical resection. Serum tumor markers and conventional radiographs are utilized to stratify patients int
Autor:
Sirisriro R, V. A. Bhadkamkar, L. P. Kasi, Euishin E. Kim, Donald A. Podoloff, Yehuda Z. Patt, R. smith, T. P. Haynie, Steven A. Curley, James L. Murray
Publikováno v:
Nuclear Medicine Communications. 17:568-576
The aims of this study were to evaluate the efficacy of scintigraphy with the 99 Tc m -labelled anti-carcinoembryonic antigen (CEA) monoclonal antibody Fab' fragment (IMMU4) in the diagnosis of recurrent colorectal carcinoma and to investigate its us
Autor:
Joan E. Cunningham, James L. Murray, Steven A. Curley, Hannah Brewer, James C. Chan, Michael G. Rosenblum, David C. Hohn, Mark Roh, Donald A. Podoloff, Hua-Zhong Zhang, William E. Fogler, Lora Thompson, Carl M. Pinsky, Viju Bhadkamkar, L. P. Kasi
Publikováno v:
Cancer. 73:850-857
Background. Previous studies in the literature have suggested that radiolabeled F(ab') 2 fragments might be superior to whole immunoglobulin G (IgG) for imaging and therapy of cancer because of their greater penetration in tumors. To test this hypoth
Autor:
V. A. Bhadkamkar, Hua‐Zhong ‐Z Zhang, Joan E. Cunningham, Donald A. Podoloff, L. P. Kasi, Daniel J. Macey, James L. Murray, Paula Trahan Rieger, Michael G. Rosenblum, Jeffrey Schlom
Publikováno v:
Cancer. 73:1057-1066
Background. Radiolabeled CC49, a second generation high affinity monoclonal antibody (MoAb) reactive with tumor-associated glycoprotein 72 (TAG72) has undergone previous Phase I testing in patients with colon cancer. Based on this report, the authors
Autor:
James L. Murray, L. P. Kasi, Kalpana Mujoo, Robert S. Benjamin, Herbert A. Fritsche, Alexander Zukiwski, Donald A. Podoloff, Hannah Brewer, Joan E. Cunningham, V. A. Bhadkamkar
Publikováno v:
Journal of Clinical Oncology. 12:184-193
PURPOSE The purpose of this phase I trial was to determine the toxicity and maximum-tolerated dose (MTD) of murine monoclonal antibody (Mab) 14G2a (anti-GD2) in cancer patients. PATIENTS AND METHODS Following tracer doses of iodine-131-labeled 14G2a
Publikováno v:
Radiology. 176:691-694
In an effort to improve hepatic uptake of liposomes for drug delivery, empty vesicles were administered by means of selective arterial infusion. Negatively charged, multilamellar liposomes were labeled with technetium-99m and infused into healthy adu
Autor:
L P Kasi, D Andreopoulos
Publikováno v:
Journal of microencapsulation. 14(4)
The uniquely structured diphytanoylphosphatidylcholine (DphPC) forms liposomes more stable than conventional straight chain phospholipids. In this study DphPC and pegylated DphPC (DphPC-PEG) liposomes were radiolabelled and evaluated in vitro and in
Autor:
J L, Murray, D J, Macey, E J, Grant, M G, Rosenblum, L P, Kasi, H Z, Zhang, R L, Katz, P T, Riger, D, LeBherz, V, Bhadkamkar
Publikováno v:
Cancer research. 55
The IFNs, alpha and gamma, have been shown to enhance the tumor-associated glycoprotein (TAG-72) on adenocarcinoma cells in vitro and in mice with human breast cancer xenografts, resulting in improved targeting of monoclonal antibody CC49. To determi
Autor:
J E, Bayouth, D J, Macey, L P, Kasi, J R, Garlich, K, McMillan, M A, Dimopoulos, R E, Champlin
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 36(5)
In this Phase I clinical trial, six multiple myeloma patients who had not responded to conventional therapy and were scheduled for bone marrow transplantation received a bone-seeking radiopharmaceutical for bone marrow ablation. The pharmacokinetics,